Sponsor List

Adelphi Real World: Experts in generating real-world data and shaping real-world evidence

Conducting multi-country real-world observational studies for over 25 years, grounded in extensive heritage of Adelphi’s Disease Specific Programmes™, supported by the expansion of our real-world evidence services to meet pharmaceutical client needs.

We provide a unique range of real-world data involving physicians, patients, and caregivers; achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and evidence landscaping.

PicnicHealth provides researchers with the most complete patient-level real-world data (RWD). In the U.S., an individual's medical records are fragmented across numerous sources and formats. PicnicHealth’s unique methodology of collecting records on behalf of consenting patients allows researchers to get the full picture of patients’ experiences across all sites of care. Consenting patients’ data is de-identified, aggregated, and abstracted in a customized manner to answer your priority research questions. PicnicHealth works with researchers across the life sciences, including top biopharma, to advance the development of treatments for better patient outcomes.

Pharmerit was founded in 2000 to foster creative collaboration among researchers dedicated to uncovering and communicating the value of healthcare interventions. This spirit has continued to drive us as we expanded our presence across the United States (US), Europe, and Asia. Our innovation over the last 20 years has led to the completion of thousands of projects, hundreds of publications, methodological advances, and a tangible and lasting impact on the healthcare landscape and the fields of epidemiology, HEOR, and market access.

In 2019, Pharmerit joined the OPEN Health Group to create a new unique entity equipped to be a global leader in HEOR, market access, medical communications and digital services. Together, we have grown to over 700 people in 15 offices across 6 different countries including the US, United Kingdom, The Netherlands, Germany, India, and China.

Premier Inc. (NASDAQ: PINC) is a technology-driven healthcare improvement company uniting an alliance of approximately 4,350 U.S. hospitals and health systems and more than 300,000 other providers and organizations to transform healthcare. As an industry leader, Premier has one of the most comprehensive databases of actionable, de-identified real-world data from more than 1,300 sites – integrating clinical, quality and purchasing datasets for deeper insights.

Every day, QIAGEN serves 500,000 customers globally, all seeking insights from DNA and RNA. Delivering Sample to Insight solutions for molecular testing, we help scientists and clinicians achieve breakthroughs in life sciences research, molecular diagnostics and drug development. This is how we make improvements in life possible. In healthcare and academic institutions, and drug-discovery and forensic laboratories, QIAGEN solutions advance disease detection and treatments, enable precision medicine, and aid crime detection and human identification.

Verantos is the market leader in high accuracy real-world evidence (RWE) generation. The Verantos RWE platform integrates heterogenous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use. The Verantos RWE platform leverages data science and artificial intelligence along with advanced data sources to generate RWE capable of supporting clinical assertions.

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

We share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients supporting a diverse, equitable and inclusive culture.

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Molecular Connections (MC), is a pioneering In-silico discovery services company founded by professionals with proven expertise in drug-discovery, biocuration, informatics and information technology. MC offers best-in-class services in the Real World Evidence domain – from evidence synthesis to performing systematic literature reviews, meta-analysis, technical writing and publication assistance. MC is also a leading supplier of manually curated databases and informatics solutions to major pharmaceuticals, high throughput data analysts and systems biology companies across the globe.

Kantar Health, a division of Kantar, provides data, analytics and research to the life sciences industry. As real-world evidence and commercialization partners, Kantar Health enables clients to bring safe and effective treatment to patients around the world. The team has expertise across a myriad of therapy areas, including unique thought leadership in oncology and rare diseases. For more information, visit www.kantar.com/expertise/health. Kantar helps clients understand people and inspire growth.

AI provides the most realistic RWE possible and since 2014, Savana is the #1 company at generating tailored RWE, using healthcare providers’ information leveraging Natural Languages Processing AI and machine learning. Savana is offering access to health data in Europe, US and LATAM. Savana designs which data sources and analysis methodologies will comply with your need, considering precision/depth of information required (variables and endpoints), timing, and geography.

Aetion delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions—what works best, for whom, and when—to guide product development, commercialization, and payment innovation.

RTI Health Solutions is a collaborative team of experts that have been collecting and analyzing prospective and retrospective real-world data for decades. We stay abreast of evolving methods and guidelines to provide you with knowledgeable support and advice throughout your product development lifecycle. Our team is here to support you with every aspect of a successful evidence-generation program, including clinical, market access, outcomes research, patient preference, economic evaluation, reimbursement, and safety activities.

LynxCare mines structured and unstructured hospital data to improve patient outcomes and make highly granular and qualitative Real-World Data accessible for life sciences research. From the pre-clinical development phase and the optimization of clinical trial designs, to measuring the value and safety of a drug, negotiations with payers/HTA bodies and post-marketing studies, LynxCare can assist life sciences to answer research questions throughout the entire drug development life cycle.